Cell Biology and Toxicology (Record no. 2375)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03649nas a22003135i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 1573-6822 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260610082503.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 150723s||||||||ne uu poo|||||| b|EN |d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1573-6822 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/10565.1573-6822 |
| Source of number or code | doi |
| 210 10 - ABBREVIATED TITLE | |
| Abbreviated title | Cell Biol Toxicol |
| 245 10 - TITLE STATEMENT | |
| Title | Cell Biology and Toxicology |
| Medium | [electronic resource] : |
| Remainder of title | An International Journal Devoted to Research at the Cellular Level / |
| Statement of responsibility, etc. | edited by Xiangdong Wang. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Dordrecht : |
| Name of producer, publisher, distributor, manufacturer | Springer Netherlands : |
| -- | Imprint: Springer. |
| 300 ## - online resource | |
| Other physical details | online resource. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Cell Biology and Toxicology (CBT) is an international journal focused on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. CBT has a disease-specific scope prioritizing publications on gene and protein-based regulation, intracellular signaling pathway dysfunction, cell type-specific function, and systems in biomedicine in drug discovery and development. CBT publishes original articles with outstanding, innovative and significant findings, important reviews on recent research advances and issues of high current interest, opinion articles of leading edge science, and rapid communication or reports, on molecular mechanisms and therapies in diseases. SUBJECTS COVERED: 1. Gene and protein-based regulations in diseases CBT welcomes submissions in the fields of genomics and proteomic, functional genomics and proteomics, computational biology, and gene expression and function. CBT particularly includes aspects of the multifactorial genetics and epigenetics of diseases, disease-specific biomarkers, developmental biology, systems biology and bioinformatics-based data mining approaches with translational potentials. 2. Molecular pharmacology and toxicology CBT specially focuses on drug target identification and validation, rational drug design, genetic/small molecule (high-throughput) screening, novel therapeutic approaches, combinatorial and parallel synthesis of drugs, pharmacokinetics and pharmacodynamics, pharmacogenomics and toxicogenomics. 3. Pathological mechanisms related with intracellular organelles and cells CBT publishes novel findings on membrane biology and domains, and the associated receptor and non-receptor mediated signaling and transport proteins of the cell membrane, mitochondria, the endoplasmic reticulum, Golgi apparatus, and other organelles in health and disease. On the cellular and organism level, CBT aims to understanding cancer development, maintenance and treatment resistance, immune and inflammatory cell function, neuroscience, stem cell development and differentiation, epithelial biology and endothelial barrier function. 4. Biomedical aspects of organ systems in diseases CBT primarily publishes studies on the immune system, central and autonomic nervous systems, gastrointestinal system, cardiovascular and circulatory system, endocrine system, and pulmonary system, skeletal and muscular system, and urinary system to understand deeper about pathogeneses and therapies. . |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biochemistry. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Biology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chemical Biology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, Xiangdong. |
| Relator term | editor. |
| Relationship | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed version: |
| International Standard Serial Number | 0742-2091 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/10565.1573-6822">https://doi.org/10.1007/10565.1573-6822</a> |
| Public note | Open Access |
No items available.